Related content

Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study

By Ceravolo R.   Volterrani D.   Gambaccini G.   Bernardini S.   Rossi C.   Logi C.   Tognoni G.   Manca G.   Mariani G.   Bonuccelli U.   Murri L.  

Journal of Neural Transmission, Vol. 111, Iss. 8, 2004-08 ,pp. : 1065-1073

Springer Publishing Company

Access to resources Recommend Favorite

Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease

By Avanzi M.   Uber E.   Bonfà F.  

Neurological Sciences, Vol. 25, Iss. 2, 2004-06 ,pp. : 98-101

Springer Publishing Company

Access to resources Recommend Favorite

Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease

By Harding A.J.   Stimson E.   Henderson J.M.   Halliday G.M.  

Brain, Vol. 125, Iss. 11, 2002-11 ,pp. : 2431-2445

Oxford University Press

Access to resources Recommend Favorite

Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson’s disease from essential tremor

By Pellicano C.   Buttarelli F. R.   Circella A.   Tiple D.   Giovannelli M.   Benincasa D.   Colosimo C.   Pontieri F. E.  

Journal of Neural Transmission, Vol. 114, Iss. 7, 2007-07 ,pp. : 935-938

Springer Publishing Company

Access to resources Recommend Favorite

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

By Bohnen Nicolaas   Gedela Satyanarayana   Kuwabara Hiroto   Constantine Gregory   Mathis Chester   Studenski Stephanie   Moore Robert  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 84-90

Springer Publishing Company

Access to resources Recommend Favorite